Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28285520 | 0.89 | ADORA1 (0.39) | GLAPOLBPDK2ADORA3ADORA2A | |
| SCHEMBL3697669 | 0.89 | GLA (0.38) | GLAPOLBKDM4CADORA3ADORA2A | |
| SCHEMBL28286871 | 0.89 | GLA (0.38) | GLAPOLBKDM4CPDK2ADORA3 | |
| SCHEMBL3693696 | 0.80 | GLA (0.38) | GLAPOLBKDM4CADORA3ADORA2A | |
| SCHEMBL28285467 | 0.80 | ADORA1 (0.39) | GLAPOLBADORA3ADORA2AADORA1 | |
| SCHEMBL3698722 | 0.80 | ADORA1 (0.39) | GLAPDK2ADORA3ADORA2AADORA1 | |
| SCHEMBL15789632 | 0.78 | ALDH1A1 (0.46) | ALDH1A1MAPK1 | |
| SCHEMBL3704415 | 0.77 | PDK2 (0.37) | GLAPOLBPDK2ADORA3ADORA2A | |
| SCHEMBL3701645 | 0.77 | GLA (0.39) | GLAPOLBKDM4CPDK2ADORA3 | |
| SCHEMBL4356818 | 0.77 | GLA (0.35) | GLAPOLBKDM4CADORA3ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3481878-B1 | AMINE COMPOSITION USEFUL FOR MAKING POLYURETHANE FOAM | EVONIK OPERATIONS GMBH (DE) | 2024-05-22 | — | — | EP | disclosed |
| CN-109476803-B | Amine compositions useful for making polyurethane foams | 赢创运营有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-11021561-B2 | Amine composition useful for making polyurethane foam | EVONIK OPERATIONS GMBH (DE) | 2021-06-01 | — | — | US | disclosed |
| EP-3481878-A1 | AMINE COMPOSITION USEFUL FOR MAKING POLYURETHANE FOAM | Evonik Degussa GmbH (DE) | 2019-05-15 | — | — | EP | disclosed |
| CN-109476803-A | It can be used for manufacturing the amine composition of polyurethane foam | 赢创德固赛有限公司 | 2019-03-15 | — | — | CN | disclosed |
| WO-2018013590-A1 | AMINE COMPOSITION USEFUL FOR MAKING POLYURETHANE FOAM | EVONIK DEGUSSA GMBH (DE) | 2018-01-18 | — | — | WO | disclosed |
| US-20180009930-A1 | AMINE COMPOSITION USEFUL FOR MAKING POLYURETHANE FOAM | EVONIK OPERATIONS GMBH (DE) | 2018-01-11 | — | — | US | disclosed |
| US-9018387-B2 | Complexes of imidazole ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-04-28 | — | — | US | disclosed |
| EP-2371821-B1 | Volatile imidazoles and group 2 imidazole based metal precursors | AIR PROD & CHEM (US) | 2014-06-18 | — | — | EP | disclosed |
| US-8680289-B2 | Complexes of imidazole ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| EP-2580223-A1 | COMPLEXES OF IMIDAZOLE LIGANDS | Air Products and Chemicals, Inc. (US) | 2013-04-17 | — | — | EP | disclosed |
| US-20130078391-A1 | Complexes Of Imidazole Ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| US-20120121806-A1 | Complexes Of Imidazole Ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| WO-2011156699-A1 | COMPLEXES OF IMIDAZOLE LIGANDS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2011-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130078391-A1 | Complexes Of Imidazole Ligands | ICOSLG, CLTC, PICALM | GLA 2364/4885POLB 3561/4885KDM4C 715/4885 |
| US-20120121806-A1 | Complexes Of Imidazole Ligands | ICOSLG, CLTC, PICALM | GLA 2364/4885POLB 3561/4885KDM4C 715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.